MORE THAN 30%
OF HOSPITAL ACQUIRED INFECTIONS ARE RELATED TO CATHETER USE
We founded Pyriscence LLC to design a revolutionary anti-microbial catheter that aims to reduce catheter associated UTIs, one of healthcare’s largest and most expensive problems. More than 30% of hospital acquired infections are related to catheter use. We learned this as first year medical students, but it wasn’t until we began working in the hospital and saw firsthand how these infections negatively impact our patients’ lives that we started working on this problem. Through research and collaboration with faculty across the University of Michigan, we have developed a novel catheter which produces reactive oxygen capable of destroying bacteria, one of the same weapons used by white blood cells in your body to battle invading organisms.
We're a team of medical students who are passionate about caring for our patients and decided to get together to solve one of healthcare's biggest problems. Learn more about the team and what motivated us to begin work on this project.
CEO & Cofounder
Alex is a 4th year medical student at the University of Michigan Medical School. He earned a Bachelor's of Science at the University of Michigan in 2014 with a double major in physics and astronomy and a minor in biophysics.
"The most rewarding thing about working on this venture is getting to tackle a problem that nobody knows the answer to. In medical school, you get really good at remembering the knowledge passed down by others and reciting it when needed-- All the while, though, there is someone that knows the next step, the next test to order, maybe even the diagnosis. This venture has forced me to forge my own path, and it's exciting to come in every morning and not know what to expect, not know what I will learn that day." -- Alex Blaty
CFO & Cofounder
Tom grew up in a rural area in Minnesota and attended the University of Minnesota for undergrad where he earned a Neuroscience BS.
"The thing that motivates me most is the huge gap in the current technology. So many things have been tried, but they inevitably don't work out. Our method is quite novel, nothing like it has been tried, and every success in the lab makes me more and more optimistic that what I'm spending my time working on is a game changer. " -- Tom Goslinga
Learn about the multidimensional considerations of bringing our device to market, our market research/analysis, clinical considerations, in-vitro testing in our lab, and the engineering and production research we have done.
After seeing the impact of Catheter Associated Infections on the patients they were taking care of, Tom and Alex got together to find a better solution. In 2016, they formed Pyriscence LLC and developed the initial prototype of their revolutionary Foley catheter. In December of that year, they won the MIG/SCRUBS Shark Tank competition, raising enough capital to expand In-Vitro testing and demonstrate efficacy against S. aureus, E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Since then, they have continued refining their design and extended their multi-disciplinary collaboration to the University of Michigan Law School, where they've begun working with the Zell Entrepreneurship and Law program to develop a business plan and intellectual property rights.
Over the next year, they will continue to refine their prototype and begin in-vivo testing in cadaveric and animal models to better study the efficacy and safety of their device in a system that closely models the human body.
Get in Touch
If you share our passion for disruptive technology, please reach out and express your interest. We are looking for inspired minds to collaborate with us as co-conspirators, investors and business partners.